Impel Neuropharma Inc (IMPL)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-19 | S Sale | Large shareholder |
28,632
-9.3%
0.08USD 2,291 |
28,632 -9.3% | 0.08 | USD 2,291 | |
| 2023-12-19 | 2023-12-19 | S Sale | Large shareholder |
208,657
-9.3%
0.08USD 16,693 |
208,657 -9.3% | 0.08 | USD 16,693 | |
| 2023-12-19 | 2023-12-18 | S Sale | Large shareholder |
28,682
-8.5%
0.11USD 3,155 |
28,682 -8.5% | 0.11 | USD 3,155 | |
| 2023-12-19 | 2023-12-18 | S Sale | Large shareholder |
209,029
-8.5%
0.11USD 22,993 |
209,029 -8.5% | 0.11 | USD 22,993 | |
| 2023-12-19 | 2023-12-15 | S Sale | Large shareholder |
12,066
-3.5%
0.29USD 3,499 |
12,066 -3.5% | 0.29 | USD 3,499 | |
| 2023-12-19 | 2023-12-15 | S Sale | Large shareholder |
87,934
-3.5%
0.29USD 25,501 |
87,934 -3.5% | 0.29 | USD 25,501 | |
| 2021-11-22 | 2021-11-19 | B Purchase | Non-Executive Director |
10,000
+inf%
10.76USD 107,554 |
10,000 +inf% | 10.76 | USD 107,554 | |
| 2021-04-29 | 2021-04-27 | B Purchase |
Norwest Venture Partners XIV, LP Large shareholder |
825,000
+36.6%
15.00USD 12,375,000 |
825,000 +36.6% | 15.00 | USD 12,375,000 | |
| 2021-04-29 | 2021-04-27 | B Purchase |
venBio Global Strategic Fund II L.P. Large shareholder |
450,000
+19.5%
15.00USD 6,750,000 |
450,000 +19.5% | 15.00 | USD 6,750,000 | |
| 2021-04-29 | 2021-04-27 | B Purchase | Large shareholder |
575,000
+inf%
15.00USD 8,625,000 |
575,000 +inf% | 15.00 | USD 8,625,000 |